Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-06
2010-06-22
Helms, Larry R. (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S277100
Reexamination Certificate
active
07741276
ABSTRACT:
Use of IL-18 inhibitors in tumor metastasis is disclosed.
REFERENCES:
patent: 0 850 952 (1998-07-01), None
patent: 98/41232 (1998-09-01), None
patent: 99/09063 (1999-02-01), None
Ared et al Immunological review, vol. 223, p. 20-38, 2008.
Kim et al JBC, vol. 277, p. 10998-03, 2002.
Vidal-Vanaclocha et al PNAS, vol. 97, p. 734-739, Jan. 2000.
Okahara et al, Cancer Research vol. 54 p. 3233-3236, 1994.
Iwasaki et al, J Immunuther, suppl 1″ S52-60, Mar.-Apr. 2002, abstract.
Nakata et al, Anticancer Res., vole 19 p. 4131-8, 1999, abstract.
Anasagasti et al. Hepatology 25:840-846 (1997).
Bani et al. J. Natl. Cancer Inst. 83:119-123 (1991).
Bazan et al. Nature 379(6566):591 (1996).
Bertorneu et al. Clin. Exp. Metastasis 11:243-250 (1993).
Burrows et al. Cancer Res. 51:4768-4775 (1991).
Chirivi et al. Cancer Res. 53:5051-5054 (1993).
Dinarello et al. J. Leukocyte Biol. 63(6):658-664 (1998).
Fantuzzi et al. Blood 91:2118-2125 (1998).
Freedman et al. Science 249:1030-1033 (1990).
Garofalo et al. Cancer Res. 55:414-419 (1995).
Kohn et al. Cancer Res., 55(9):1856-1862 (1995).
Lauri et al. Clin. Exp. Metastasis 8:27-32 (1990).
Malik et al. Eur. J. Cancer 26:1031-1034 (1990).
Martin-Padura et al. Cancer Res. 51:2239-2241 (1991).
Mendoza et al. J. Cell Physiol. 174:322-330 (1998).
Miyake et al. Res. Comm. Chem. Pathol. Pharmacol. 71:293-307 (1991).
Nicolson et al. Nature 255:230-232 (1975).
Novick et al. Immunity 10:127-136 (1999).
Okahara et al. Cancer Res. 54:3233-3236 (1994).
Okamura et al. Nature 378:88-91 (1995).
Orosz et al. Int. J. Cancer 60:867-871 (1995).
Orosz et al. J. Exp. Med. 177:1391-1398 (1993).
Pages et al. Immunology Letters 68(1):135-139 (1999).
Puren et al. J. Clin. Invest 101(3):711-724 (1998).
Rice et al. Science 246:1303-1306 (1989).
Simmons et al. Blood 80(2):388-95 (1992).
Tsutsui et al. J. Immunol. 159(8):3961-3967 (1997).
Vidal-Vanaclocha et al. Cancer Res. 54:2667-2672 (1994).
Vidal-Vanaclocha et al. Cytokine 9(11):897 (1997).
Vidal-Vanaclocha et al. Hepatology 18:328-339 (1993).
Vidal-Vanaclocha et al. J. Natl. Cancer Inst. 88:198-205 (1996).
Vidal-Vanaclocha et al. PNAS 97(2):734-739 (2000).
Nakata et al., Anticancer Res. 19:4131-8, 1999.
Ligo et al., Cytokine 25:36-44, 2004.
Freshney, Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p4.
Dermer, Bio/Technology, 1994, vol. 12, p. 320.
Gura, Science, vol. 278, p. 1041-1042, 1997.
Ares Trading S.A.
Helms Larry R.
Nixon & Peabody LLP
Yao Lei
LandOfFree
Use of interleukin-18 inhibitors to inhibit tumor metastasis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of interleukin-18 inhibitors to inhibit tumor metastasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of interleukin-18 inhibitors to inhibit tumor metastasis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244686